Concepedia

Valérie Boullay

VB

3

Publications

406

Citations

3

H-Index

2004

Active since

Affiliations

GlaxoSmithKline (France)(Current)

GlaxoSmithKline (United Kingdom)

Valérie Boullay is an author at GlaxoSmithKline (France) specializing in pharmacology, medicine, and molecular pharmacology.

Top concepts

Publications per year

2004–2015

3

Publications

3

Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors

Françoise Gellibert, James M. Woolven, Marie-Hélène Fouchet et al. · Journal of Medicinal Chemistry · 2004 · 217 citations · Full text

Inhibition of TGF‐<i>β</i> signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis

Anne‐Charlotte de Gouville, Valérie Boullay, Gaël Krysa et al. · British Journal of Pharmacology · 2005 · 164 citations · Full text

, , +18

Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist

Dennis L. Sprecher, Miles Maxwell, Joanne Goodman et al. · European Journal of Pharmacology · 2015 · 25 citations

, , +8

Rows per page

1–3 of 3